Coverage dated November 25, 2021 to November 28, 2021
Pfizer CEO says they've started developing new COVID vaccine amid Omicron spread Headline from Newsweek, on the newest of 2 developments
Pfizer CEO Albert Bourla said his company could have a new vaccine available in less than 100 days, if necessary.
Newsweek's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update 2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Nov 26, 2021
Moderna testing 3 COVID-19 booster vaccines on omicron variant, Pfizer ready to adapt
Headline from Foxla · 3 reports in this development
Nov 29, 2021 Newest
Pfizer CEO says they've started developing new COVID vaccine amid Omicron spread
Headline from Newsweek · 7 reports in this development
Reports & sources Newest first Show outlet leaning
Filter reports by outlet or headline words
10 articles, oldest first.
Foxla
Moderna testing 3 COVID-19 booster vaccines on omicron variant, Pfizer ready to adapt ↗ (opens Foxla) Published Nov 25, 2021
Foxla's feed description Pfizer said if any coronavirus variant ever evades the protection offered by its COVID-19 vaccine, it expects to be able to produce a “tailor-made” adapted version of its vaccine to fight that variant in approximately 100 days, pending approval from federal regulators.
CBS News
Pfizer testing its vaccine against new COVID-19 strain ↗ (opens CBS News) Published Nov 25, 2021
CBS News's feed description Drugmaker said it could develop a vaccine for the Omicron variant in 100 days, but government clearance could take longer.
Insider
Pfizer said an updated version of its COVID-19 vaccine will be 'ready in 100 days' if the new Omicron variant is resistant to its current vaccine ↗ (opens Insider) Published Nov 26, 2021
Insider's feed description Pfizer expects to know within two weeks whether the variant is resistant to its current vaccine, a company spokesperson told Reuters.
Newsweek
Pfizer CEO says they've started developing new COVID vaccine amid Omicron spread ↗ (opens Newsweek) Published Nov 28, 2021
Newsweek's feed description Pfizer CEO Albert Bourla said his company could have a new vaccine available in less than 100 days, if necessary.
Towleroad Gay News
Pfizer Already Working On Covid Vaccine Targeting Omicron: CEO ↗ (opens Towleroad Gay News) Published Nov 28, 2021
Same headline from 2 more outlets Towleroad Gay News's feed description New York (AFP) - Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the Omicron variant in case the current
The Times of Israel
The Times of Israel
Pfizer CEO: We’re working on COVID vaccine against Omicron ↗ (opens The Times of Israel) Published Nov 28, 2021
The Times of Israel's feed description Albert Bourla says new shot may be needed if testing shows existing vaccine provides less protection against new coronavirus variant
The Hill
Pfizer CEO has 'high level of confidence' COVID-19 pill will be effective against omicron ↗ (opens The Hill) Published Nov 28, 2021
The Hill's feed description Pfizer CEO Albert Bourla said Monday he has "a very high level of confidence” that his company's COVID-19 treatment pills are effective against he omicron variant.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
